Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
The ability of factor VIIa to initiate thrombin generation and clot formation in blood from healthy donors, blood from patients with hemophilia A, and in anti-factor IX antibody-induced ("acquired") hemophilia B blood was investigated. In normal blood, both factor VIIa-tissue factor (TF) complex and factor VIIa alone initiated thrombin generation. The efficiency of factor VIIa was about 0.0001 that of the factor VIIa-TF complex. In congenital hemophilia A blood and "acquired" hemophilia B blood in vitro, addition of 10 to 50 nM factor VIIa (pharmacologic concentrations) corrected the clotting time at all TF concentrations tested (0-100 pM) but had little effect on thrombin generation. Fibrinopeptide release and insoluble clot formation were only marginally influenced by addition of factor VIIa. TF alone had a more pronounced effect on thrombin generation; an increase in TF from 0 to 100 pM increased the maximum thrombin level in "acquired" hemophilia B blood from 120 to 480 nM. Platelet activation was considerably enhanced by addition of factor VIIa to both hemophilia A blood and "acquired" hemophilia B blood. Thus, pharmacologic concentrations of factor VIIa cannot restore normal thrombin generation in hemophilia A and hemophilia B blood in vitro. The efficacy of factor VIIa (10-50 nM) in hemophilia blood is dependent on TF.
Butenas
Saulius
S
College of Medicine, University of Vermont, 89 Beaumont Ave, Burlington, VT 05405-0068, USA.
Brummel
Kathleen E
KE
Branda
Richard F
RF
Paradis
Sara G
SG
Mann
Kenneth G
KG
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D016022:Case-Control Studies; D004305:Dose-Response Relationship, Drug; D015942:Factor VIIa / Q000378:metabolism / Q000494:pharmacology*; D005340:Fibrinogen / Q000187:drug effects / Q000378:metabolism; D006467:Hemophilia A / Q000097:blood*; D002836:Hemophilia B / Q000097:blood; D006801:Humans; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D013917:Thrombin / Q000096:biosynthesis; D013925:Thromboplastin / Q000378:metabolism / Q000494:pharmacology
D005340:Fibrinogen; D013925:Thromboplastin; D015942:Factor VIIa; D013917:Thrombin